GLP-1's, which are traditionally diabetes medications, have exploded in popularity since they were approved for weight-loss.

Eli Lilly stock crashes as late-stage data for weight-loss pill falls short of expectations. Analyst explains why data wasn't ...

The main indexes finished well off their session highs after a disappointing batch of corporate earnings reports.

ATTAIN-1 is the second trial this year to show positive results with once-daily orforglipron, with best results seen at the ...

U.S. stocks are drifting lower after President Donald Trump’s latest tariffs took effect on dozens of countries, but the moves are modest and stocks rose in much of the rest ...

Stocks are drifting on Wall Street after President Donald Trump’s latest tariffs took effect on dozens of countries. The S&P ...

The iPhone maker's shares [rallied for a second day]( ...

Eli Lilly’s LLY 38% revenue growth and 61% non-GAAP EPS growth in the second quarter were above consensus expectations.

Eli Lilly's experimental GLP-1 pill shows promise in a Phase Three trial, helping users lose an average of 12% of body weight ...

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

A joint youth group from Saint Peter’s Lutheran Church in Forestville and Saint John’s Lutheran Church in Algoma recently ...

The Red Angus Association of America has awarded scholarships to six youth leaders for their achievements in agriculture, academics, and service.